Submitting Candidates for Members of the Supervisory Board of the Company

Current Report No. 21/2022

Date of preparation: 10 June 2022

Subject: Submitting Candidates for Members of the Supervisory Board of the Company

Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") with reference to current report No. 20/2022 of 3 June 2022 containing draft resolutions for the Ordinary General Meeting of Shareholders of the Company convened for 30 June 2022, hereby informs that on 10 June 2022 it received a notification from a shareholder of the Company: Mr. Paul Holstinghausen Holsten, the following nominations for members of the Supervisory Board of the Company:

1. Mr Paul Holstinghausen Holsten;
2. Mr Robert Florczykowski;
3. Mr Florent Gros;
4. Mr Krzysztof Samotij;
5. Mr Maciej Wróblewski.

The criteria for independence from the Company and entities with significant connections with the Company set out in Article 129(3) of the Act of 11 May 2017 on statutory auditors, audit firms and public supervision (i.e. Journal of Laws of 2020, item 1415, as amended) are met by the following candidates:

1. Mr Robert Florczykowski;
2. Mr Florent Gros;
3. Mr Krzysztof Samotij.

At the same time, the Management Board of the Company, in the attachment to this report, makes public the professional CVs of the above-mentioned candidates and the content of the statements and consents to stand as candidates submitted by them, as well as the content of the notice from the shareholder with draft resolutions.

Detailed legal basis: § 19 (1) (4) of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required by the laws of a non-member state.